KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $739.2 million.

  • Zimmer Biomet Holdings' Net Cash Flow rose 43218.14% to $739.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $723.5 million, marking a year-over-year increase of 16946.0%. This contributed to the annual value of $126.8 million for FY2024, which is 22346.94% up from last year.
  • As of Q3 2025, Zimmer Biomet Holdings' Net Cash Flow stood at $739.2 million, which was up 43218.14% from -$842.4 million recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' Net Cash Flow ranged from a high of $852.2 million in Q1 2025 and a low of -$842.4 million during Q2 2025
  • Over the past 5 years, Zimmer Biomet Holdings' median Net Cash Flow value was -$17.1 million (recorded in 2024), while the average stood at $33.1 million.
  • The largest annual percentage gain for Zimmer Biomet Holdings' Net Cash Flow in the last 5 years was 508362.57% (2025), contrasted with its biggest fall of 286196.72% (2025).
  • Zimmer Biomet Holdings' Net Cash Flow (Quarter) stood at -$442.2 million in 2021, then skyrocketed by 58.91% to -$181.7 million in 2022, then soared by 163.95% to $116.2 million in 2023, then crashed by 121.94% to -$25.5 million in 2024, then surged by 2998.82% to $739.2 million in 2025.
  • Its last three reported values are $739.2 million in Q3 2025, -$842.4 million for Q2 2025, and $852.2 million during Q1 2025.